M Delorenzi
Overview
Explore the profile of M Delorenzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aalders K, Kuijer A, Straver M, Slaets L, Litiere S, Viale G, et al.
Eur J Cancer
. 2017 May;
79:98-105.
PMID: 28477490
Background: In multifocal breast cancer, guidelines recommend basing adjuvant systemic treatment decisions on characteristics of the largest lesion, disregarding multifocality as an independent prognosticator. We assessed the association between multifocal...
2.
Dienstmann R, Mason M, Sinicrope F, Phipps A, Tejpar S, Nesbakken A, et al.
Ann Oncol
. 2017 Apr;
28(5):1023-1031.
PMID: 28453697
Background: TNM staging alone does not accurately predict outcome in colon cancer (CC) patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the molecular markers...
3.
Klingbiel D, Saridaki Z, Roth A, Bosman F, Delorenzi M, Tejpar S
Ann Oncol
. 2014 Nov;
26(1):126-132.
PMID: 25361982
Background: Although colon cancer (CC) with microsatellite instability (MSI) has a more favorable prognosis than microsatellite stable (MSS) CC, the impact varies according to clinicopathological parameters. We studied how MSI...
4.
Missiaglia E, Jacobs B, DArio G, Di Narzo A, Soneson C, Budinska E, et al.
Ann Oncol
. 2014 Jul;
25(10):1995-2001.
PMID: 25057166
Background: Differences exist between the proximal and distal colon in terms of developmental origin, exposure to patterning genes, environmental mutagens, and gut flora. Little is known on how these differences...
5.
Rossi S, Christ-Neumann M, Ruping S, Buffa F, Wegener D, McVie G, et al.
Ecancermedicalscience
. 2012 Jan;
5:218.
PMID: 22276060
The Worldwide innovative Networking in personalized cancer medicine (WIN) initiated by the Institute Gustave Roussy (France) and The University of Texas MD Anderson Cancer Center (USA) has dedicated its 3rd...
6.
Carrascosa C, Obula R, Missiaglia E, Lehr H, Delorenzi M, Frattini M, et al.
Oncogene
. 2011 Aug;
31(12):1521-32.
PMID: 21841820
Milk fat globule-EGF factor 8 (MFG-E8) is a glycoprotein highly expressed in breast cancer that contributes to tumor progression through largely undefined mechanisms. By analyzing publicly available gene expression profiles...
7.
Zaric J, Joseph J, Tercier S, Sengstag T, Ponsonnet L, Delorenzi M, et al.
Oncogene
. 2011 Jun;
31(1):48-59.
PMID: 21666716
Cyclooxyganase-2 (COX-2), a rate-limiting enzyme in the prostaglandin synthesis pathway, is overexpressed in many cancers and contributes to cancer progression through tumor cell-autonomous and paracrine effects. Regular use of non-steroidal...
8.
Meier P, Antonov J, Zbinden R, Kuhn A, Zbinden S, Gloekler S, et al.
Heart
. 2008 Aug;
95(11):900-8.
PMID: 18728069
Background: In patients with coronary artery disease (CAD), a well grown collateral circulation has been shown to be important. The aim of this prospective study using peripheral blood monocytes was...
9.
Bacac M, Migliavacca E, Stehle J, McKee T, Delorenzi M, Coindre J, et al.
J Pathol
. 2006 Jan;
208(4):543-53.
PMID: 16440290
Nodular fasciitis (NF) is a rapidly growing cellular mass composed of fibroblasts/myofibroblasts, usually localized in subcutaneous tissues, that typically undergoes fibrosis and almost never recurs. Desmoid tumours (DTs) are rare...
10.
Triglia T, Thompson J, Caruana S, Delorenzi M, SPEED T, Cowman A
Infect Immun
. 2001 Feb;
69(2):1084-92.
PMID: 11160005
Plasmodium falciparum infections can be fatal, while P. vivax infections usually are not. A possible factor involved in the greater virulence of P. falciparum is that this parasite grows in...